These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 20883735)
21. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains. Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789 [TBL] [Abstract][Full Text] [Related]
22. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729 [TBL] [Abstract][Full Text] [Related]
23. Characterization of the immune responses elicited by baculovirus-based vector vaccines against influenza virus hemagglutinin. Hu ZP; Yin J; Zhang YY; Jia SY; Chen ZJ; Zhong J Acta Pharmacol Sin; 2012 Jun; 33(6):783-90. PubMed ID: 22562016 [TBL] [Abstract][Full Text] [Related]
24. A vaccination strategy to enhance mucosal and systemic antibody and T cell responses against influenza. Vajdy M; Baudner B; Del Giudice G; O'Hagan D Clin Immunol; 2007 May; 123(2):166-75. PubMed ID: 17349825 [TBL] [Abstract][Full Text] [Related]
25. Mucosal immunization with attenuated Shigella flexneri harboring an influenza hemagglutinin DNA vaccine protects mice against a lethal influenza challenge. Vecino WH; Quanquin NM; Martinez-Sobrido L; Fernandez-Sesma A; García-Sastre A; Jacobs WR; Fennelly GJ Virology; 2004 Aug; 325(2):192-9. PubMed ID: 15246259 [TBL] [Abstract][Full Text] [Related]
26. Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice. Okamoto S; Matsuura M; Akagi T; Akashi M; Tanimoto T; Ishikawa T; Takahashi M; Yamanishi K; Mori Y Vaccine; 2009 Sep; 27(42):5896-905. PubMed ID: 19647814 [TBL] [Abstract][Full Text] [Related]
27. Oral immunization with recombinant Lactococcus lactis expressing the hemagglutinin of the avian influenza virus induces mucosal and systemic immune responses. Wang Z; Gao J; Yu Q; Yang Q Future Microbiol; 2012 Aug; 7(8):1003-10. PubMed ID: 22913358 [TBL] [Abstract][Full Text] [Related]
28. Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity. Okamoto S; Yoshii H; Akagi T; Akashi M; Ishikawa T; Okuno Y; Takahashi M; Yamanishi K; Mori Y Vaccine; 2007 Nov; 25(49):8270-8. PubMed ID: 17977633 [TBL] [Abstract][Full Text] [Related]
29. Sindbis virus vectors elicit hemagglutinin-specific humoral and cellular immune responses and offer a dose-sparing strategy for vaccination. Miller A; Center RJ; Stambas J; Deliyannis G; Doherty PC; Howard JL; Turner SJ; Purcell DF Vaccine; 2008 Oct; 26(44):5641-8. PubMed ID: 18761047 [TBL] [Abstract][Full Text] [Related]
30. Baculovirus-produced influenza virus-like particles in mammalian cells protect mice from lethal influenza challenge. Tang XC; Lu HR; Ross TM Viral Immunol; 2011 Aug; 24(4):311-9. PubMed ID: 21830902 [TBL] [Abstract][Full Text] [Related]
31. An α-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccine. Lee YS; Lee KA; Lee JY; Kang MH; Song YC; Baek DJ; Kim S; Kang CY Vaccine; 2011 Jan; 29(3):417-25. PubMed ID: 21087689 [TBL] [Abstract][Full Text] [Related]
32. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection. Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010 [TBL] [Abstract][Full Text] [Related]
33. Construction of recombinant baculoviruses expressing hemagglutinin of H5N1 avian influenza and research on the immunogenicity. Ge J; An Q; Gao D; Liu Y; Ping W Sci Rep; 2016 Apr; 6():24290. PubMed ID: 27063566 [TBL] [Abstract][Full Text] [Related]
38. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice. Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483 [TBL] [Abstract][Full Text] [Related]
39. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice. Zhang L; Lu J; Chen Y; Shi F; Yu H; Huang C; Cui L; Shi Z; Jiao Y; Hu Y Viruses; 2015 Aug; 7(8):4369-84. PubMed ID: 26248076 [TBL] [Abstract][Full Text] [Related]
40. Protective efficacy of a human endogenous retrovirus envelope-coated, nonreplicable, baculovirus-based hemagglutin vaccine against pandemic influenza H1N1 2009. Choi JY; Gwon YD; Kim JK; Cho YD; Heo YK; Cho HS; Choi TJ; Poo HR; Oh YK; Kim YB PLoS One; 2013; 8(11):e80762. PubMed ID: 24260476 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]